Patricky Yang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sana Biotechnology (NASDAQ:SANA – Get Rating) had its price objective lowered by research analysts at Morgan Stanley to $15.00 in a research note issued to investors on Tuesday, Stock Target Advisor reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective suggests a potential upside of 206.12% from the stock’s […]

Sana Biotechnology, Inc. (NASDAQ:SANA – Get Rating) gapped up prior to trading on Tuesday . The stock had previously closed at $8.68, but opened at $9.03. Sana Biotechnology shares last traded at $9.15, with a volume of 2,845 shares trading hands. Separately, Zacks Investment Research downgraded shares of Sana Biotechnology from a “hold” rating to […]